Yueyue Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yueyue Li has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
- Yanqing Li
Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China
27 shared publications - Xiuli Zuo
Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China
21 shared publications Qingzhou Kong
Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University , Jinan, Shandong
20 shared publicationsMiao Duan
Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University , Jinan, Shandong
18 shared publications- Ruchen Zhou
Qilu Hospital of Shandong University 1 Department of Gastroenterology Jinan, China
14 shared publications Yanqing Li
Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University , Jinan, Shandong
14 shared publications
Latest Publications
- 3 August 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Cold Snare Polypectomy for 5–9 mm Small Bowel Polyps in Patients With Peutz-Jeghers Syndrome by Double-Balloon Enteroscopy: A Prospective Clinical Trial
AIMS:Evaluating the feasibility of cold snare polypectomy (CSP) for small-bowel polyps in patients with Peutz-Jeghers syndrome (PJS).METHODS:PJS...
- 3 August 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Cold Snare Polypectomy for 5–9 mm Small Bowel Polyps in Patients With Peutz-Jeghers Syndrome by Double-Balloon Enteroscopy: A Prospective Clinical Trial
AIMS:Evaluating the feasibility of cold snare polypectomy (CSP) for small-bowel polyps in patients with Peutz-Jeghers syndrome (PJS).METHODS:PJS...
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S9. Nomogram for predicting the risk of advanced colorectal neoplasia in asymptomatic patients. The nomogram integrates the same seven predictors as the main model, developed specifically for the asymptomatic screening population (n = 2,704). ACRN, advanced colorectal neoplasia; BMI, body mass index.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S9. Nomogram for predicting the risk of advanced colorectal neoplasia in asymptomatic patients. The nomogram integrates the same seven predictors as the main model, developed specifically for the asymptomatic screening population (n = 2,704). ACRN, advanced colorectal neoplasia; BMI, body mass index.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Background:This study aimed to develop and externally validate a risk stratification model for advanced colorectal neoplasia (ACRN) based on the quantitative fecal immunochemical test (FIT) and easily available clinical data.Methods:Data were derived from a multicenter study, comprising 3,209 individuals in the development set and 1,678 in the validation set. Significant risk factors for ACRN were identified using multivariable logistic regression. The area under the receiver operating characteristic curve (AUROC) and the Hosmer–Lemeshow goodness-of-fit test were used to evaluate model performance. After point assignments based on the regression coefficients, patients in the validation set were categorized into low-, intermediate-, high-, and very high–risk tiers.Results:Age, sex, body mass index, habitual residence, alcohol intake, smoking, and fecal hemoglobin concentration were identified as significant risk factors for ACRN. The model demonstrated strong predictive performance (AUROC = 0.870) and good calibration (P = 0.929). The corresponding prevalence of ACRN in the low-, intermediate-, high-, and very high–risk tiers was 1.66%, 4.50%, 28.45%, and 60.64%, respectively. Subjects in the intermediate-, high-, and very high–risk tiers had 2.71-, 17.13-, and 36.51-fold higher risk of ACRN, respectively, compared with those in the low-risk tier.Conclusions:This model can effectively stratify the risk of ACRN. Individuals in the high-risk and very high–risk groups should undergo colonoscopy promptly. Furthermore, it may help compensate for the low detection rate of FIT for advanced adenoma.Impact:This model provides clinicians with a complementary approach to colorectal cancer screening strategy and may help optimize the efficiency of screening resource allocation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Background:This study aimed to develop and externally validate a risk stratification model for advanced colorectal neoplasia (ACRN) based on the quantitative fecal immunochemical test (FIT) and easily available clinical data.Methods:Data were derived from a multicenter study, comprising 3,209 individuals in the development set and 1,678 in the validation set. Significant risk factors for ACRN were identified using multivariable logistic regression. The area under the receiver operating characteristic curve (AUROC) and the Hosmer–Lemeshow goodness-of-fit test were used to evaluate model performance. After point assignments based on the regression coefficients, patients in the validation set were categorized into low-, intermediate-, high-, and very high–risk tiers.Results:Age, sex, body mass index, habitual residence, alcohol intake, smoking, and fecal hemoglobin concentration were identified as significant risk factors for ACRN. The model demonstrated strong predictive performance (AUROC = 0.870) and good calibration (P = 0.929). The corresponding prevalence of ACRN in the low-, intermediate-, high-, and very high–risk tiers was 1.66%, 4.50%, 28.45%, and 60.64%, respectively. Subjects in the intermediate-, high-, and very high–risk tiers had 2.71-, 17.13-, and 36.51-fold higher risk of ACRN, respectively, compared with those in the low-risk tier.Conclusions:This model can effectively stratify the risk of ACRN. Individuals in the high-risk and very high–risk groups should undergo colonoscopy promptly. Furthermore, it may help compensate for the low detection rate of FIT for advanced adenoma.Impact:This model provides clinicians with a complementary approach to colorectal cancer screening strategy and may help optimize the efficiency of screening resource allocation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S2. Restricted cubic spline analysis of fecal immunochemical test (FIT) values by different methods. This diagram showed restricted cubic spline analysis for different methods: (a) logarithmic transformation [log(1+FIT)], (b) rank trans formation, (c) winsorization transformation and (d) raw FIT values.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S2. Restricted cubic spline analysis of fecal immunochemical test (FIT) values by different methods. This diagram showed restricted cubic spline analysis for different methods: (a) logarithmic transformation [log(1+FIT)], (b) rank trans formation, (c) winsorization transformation and (d) raw FIT values.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S1. Distribution analysis of fecal immunochemical test (FIT) values by different methods. This diagram systematically evaluated four alternative approaches for handling the skewed distribution of raw FIT values (a): winsorization transformation (b), logarithmic transformation [log(1+FIT)] (c), rank transformation (d) and categorized transformation (e).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S1. Distribution analysis of fecal immunochemical test (FIT) values by different methods. This diagram systematically evaluated four alternative approaches for handling the skewed distribution of raw FIT values (a): winsorization transformation (b), logarithmic transformation [log(1+FIT)] (c), rank transformation (d) and categorized transformation (e).